The Quality of Life of a Teenager with Rasmussen’s Encephalitis — Case Report
DOI:
https://doi.org/10.15225/PNN.2018.7.1.4Keywords
Rasmussen Encephalitis, case reports, quality of lifeAbstract
Introduction. Rasmussen’s Syndrome (RE), is a rare type of chronic focal encephalitis (CFE) of unexplained etiology and progressive course. It is characterized by resistant to treatment epileptic seizures. Mainly, these are epilepsy partialis continua (EPC) seizures. In the course of the disease, regress of cognitive function and progressive neurological deficits follow, primarily, hemiparesis. Quality of life examination is an expression of a holistic approach towards the patient. These studies are really important in the chronic diseases. Apart from the time of survival, they may be the dependent variable in the models of, treatment effectiveness of and care assessment.
Case Report. The case study concerns a 15- year-old sick girl, whose neurological condition, has been steadily deteriorating — aphasia and dementia dominate, hemiparesis is low. The assessment of the quality of the patient’s life was assessed by the pediatric quality of life questionnaire (PedsQL 4.0)
Discussion. Subjective assessment of the quality of life assessed by the patient, is a source of information, which is often different from the assessment made by the girl’s mother. Furthermore, subjective evaluation suggests for existence of patient’s needs that are imperceptible, which require professional care and assistance outside the hospital environment.
Conclusions. The patient with RE is characterized by complexity and a multitude of health problems. According to the assessment made by the girl the quality of her life is lower compared to the answers given by the mother. (JNNN 2018;7(1):33–39)
References
Juszczyk J. Wirusowe zapalenie opon mózgowo-rdzeniowych i mózgu. Padaczka. W: Kozubski W., Liberski P.P. (Red.), Neurologia. Podręcznik dla studentów medycyny. Wydawnictwo Lekarskie PZWL, Warszawa 2006;404.
Rasmussen T., Olszewski J., Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology. 1958;8(6):435–445.
Watson R., Jiang Y., Bermudez I. et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology. 2004;63(1):43–50.
Czochańska J., Szczepanik E., Pakszys M. Zespoły padaczkowe u dzieci i młodzieży. Wyd. BiFolium, Lublin 2002;153–160.
Topçu M., Turanli G., Aynaci F.M. et al. Rasmussen encephalitis in childhood. Childs Nerv Syst. 1999;15(8):395–403.
Arias M., Dapena D., Arias-Rivas S. Rasmussen encephalitis in the sixth decade: magnetic resonance image evolution and immunoglobulin response. Eur Neurol. 2006;56(4):236–239.
Kupczyk K., Gurda B., Steinborn B. Zespół Rasmussena — problemy diagnostyczne i terapeutyczne. Opis przypadku. Neurol Dziec. 2009;18(35):85–90.
Bien C.G., Granata T., Antozzi C. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain. 2005;128(Pt 3):454–471.
Stahnisch F.W., Nakashima A.S. Theodore Brown Rasmussen (1910–2002). J Neurol. 2013;260(10):2694–2696.
Vein A.A., van Emde Boas W. Kozhevnikov epilepsy: the disease and its eponym. Epilepsia. 2011;52(2):212–218.
Dąbrowska J., Sendrowski K., Artemowicz B. i wsp. Zespół Kożewnikowa u 12-letniego chłopca. Ewolucja obrazu i przebiegu klinicznego. Neurol Dziec. 2011;20(41):141–147.
Lenart-Domka E. Przebieg rehabilitacji pacjentki z zespołem Rasmussena — opis przypadku. Prz Med Uniw Rzesz Inst Leków. 2014;3:294–301.
Schmalbach B., Lang N. New hope for Rasmussen encephalitis? Discov Med. 2009;8(42):130–132.
Granata T., Andermann F. Rasmussen encephalitis. Handb Clin Neurol. 2013;111:511–519.
Shioda M., Oguni H., Ito Y. et al. Three children with Rasmussen encephalitis showing marked improvement in daily life activity following the functional hemispherectomy. No To Hattatsu. 2011;43(5):373–377.
[No authors listed]. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409.
Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
Bergner M. Quality of life, health status, and clinical research. Med Care. 1989;27(3 Suppl):S148–156.
Majkowicz M., Zdun-Ryżewska A. Ocena jakości życia w zaburzeniach psychicznych — koncepcje, badania, narzędzia pomiaru. Psychiatr Prakt Klin. 2009;2(2):100–114.
Kłak A., Mińko M., Siwczyńska D. Metody kwestionariuszowe badania jakości życia. Probl Hig Epidemiol. 2012;93(4):632–638.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 232
Number of citations: 0